DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test
At DNA Labs UAE, we offer the DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test for individuals who may be experiencing symptoms related to this genetic disorder. The test is designed to analyze the DNAI2 gene and detect any potential disease-causing mutations or variants.
Test Details
The DNAI2 gene is associated with a genetic disorder known as primary ciliary dyskinesia type 9. This disorder affects the function of cilia, which are hair-like structures that line various organs, including the respiratory tract and fallopian tubes. Mutations in the DNAI2 gene can lead to impaired cilia movement, resulting in symptoms such as chronic respiratory infections, infertility, and abnormal organ placement.
Our DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the analysis of multiple genes simultaneously. By sequencing the DNAI2 gene, we can identify any potential disease-causing mutations or variants that may be present.
Test Components and Price
The DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or alternatively, one drop of blood on an FTA card.
Report Delivery and Test Method
Once the sample is received, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology for analysis.
Test Type and Doctor
The DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test falls under the category of Ear Nose Throat Disorders. The test is recommended to be performed by an ENT doctor.
Test Department and Pre Test Information
The DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test is conducted in our Genetics department. It is advised to provide the clinical history of the patient who is also undergoing the EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A genetic counseling session is recommended to draw a pedigree chart of family members affected with the EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA19.
Benefits of the Test
The DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test can be highly beneficial in diagnosing primary ciliary dyskinesia type 9 and providing valuable information about the specific genetic variant present in an individual. This information can be used for genetic counseling, family planning, and potentially guiding treatment decisions.
| Test Name | DNAI2 Gene Primary ciliary dyskinesia type 9 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA19 |
| Test Details | The DNAI2 gene is associated with a genetic disorder called primary ciliary dyskinesia type 9. This disorder affects the function of cilia, which are hair-like structures that line the respiratory tract, fallopian tubes, and other organs. Mutations in the DNAI2 gene can lead to impaired cilia movement, resulting in symptoms such as chronic respiratory infections, infertility, and abnormal situs (organ placement). NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, allowing for the identification of genetic variants or mutations that may be associated with a particular disorder. In the case of primary ciliary dyskinesia type 9, an NGS genetic test would involve sequencing the DNAI2 gene to detect any potential disease-causing mutations or variants. This type of genetic testing can be helpful in diagnosing primary ciliary dyskinesia type 9, as well as providing information about the specific genetic variant present in an individual. This information can be used for genetic counseling, family planning, and potentially guiding treatment decisions. |
